The Duke University spinout has secured capital from 10 unnamed investors.

Istari Oncology, an oncology treatment developer spun out of Duke University, has obtained $1.1m in funding from a total of 10 undisclosed investors.

Founded in 2014 by Dani Bolognesi, Henry Friedman and Darell Bigner, Istari is developing a cure for recurrent glioblastoma, a type of brain tumour.

The company is based in Research Triangle Park, North Carolina, a research centre supporting projects from Duke University, North Carolina State University and University of North Carolina at Chapel Hill.

Bolognesi is the…